Stocks and Investing Stocks and Investing
Mon, April 17, 2023
[ 12:00 AM ] - United States, WOPRAI
Raghuram Selvaraju Reiterated (AXSM) at Strong Buy and Held Target at $200 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Richard Shane Maintained (AXP) at Hold with Decreased Target to $167 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Rescott Maintained (AXNX) at Strong Buy with Decreased Target to $73 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Robert Mason Maintained (BMI) at Hold with Increased Target to $115 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Nathan Jones Maintained (BMI) at Hold with Increased Target to $109 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Ittai Kidron Maintained (BLZE) at Buy with Decreased Target to $7.5 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Todd Brooks Reiterated (BJRI) at Strong Buy and Held Target at $38 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Bill Katz Maintained (BLK) at Hold with Increased Target to $673 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Craig Siegenthaler Maintained (BLK) at Strong Buy with Increased Target to $920 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Mike Cyprys Maintained (BLK) at Buy with Increased Target to $861 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Brown Maintained (BLK) at Hold with Increased Target to $770 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
James Fotheringham Maintained (BLK) at Hold with Decreased Target to $542 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Daniel Ives Reiterated (AAPL) at Buy and Held Target at $205 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jayson Bedford Maintained (ABT) at Buy with Decreased Target to $116 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Ryan Zimmerman Maintained (ABT) at Strong Buy with Increased Target to $130 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Nathan Jones Maintained (ZWS) at Strong Buy with Decreased Target to $24 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
James Thalacker Maintained (AEP) at Buy with Increased Target to $102 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Steve Fleishman Downgraded (AES) to Hold on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Tony Butler Reiterated (ADAP) at Strong Buy and Held Target at $10 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Richard Shane Maintained (ACT) at Hold with Decreased Target to $24 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Dylan Becker Initiated (ADSK) at Buy on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Dan Levy Maintained (ADNT) at Buy with Decreased Target to $54 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Laura Chico Maintained (APLS) at Hold with Increased Target to $67 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Laura Chico Maintained (ARDX) at Buy with Increased Target to $7 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Albanese Maintained (AREB) at Strong Buy and Held Target at $338 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Dan Levy Maintained (APTV) at Buy with Decreased Target to $142 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Saxon Maintained (ATEC) at Strong Buy and Held Target at $18 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Sison Maintained (ASH) at Hold with Decreased Target to $110 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Mike Matson Maintained (ATRC) at Strong Buy and Held Target at $58 on, Apr 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Ami Fadia Maintained (AVDL) at Strong Buy and Held Target at $11 on, Apr 17th, 2023

Ami Fadia Maintained (AVDL) at Strong Buy and Held Target at $11 on, Apr 17th, 2023


Published on 2024-10-28 02:47:11 - WOPRAI, Ami Fadia
  Print publication without navigation


Ami Fadia of Needham, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy and Held Target at $11 on, Apr 17th, 2023.

Ami has made no other calls on AVDL in the last 4 months.



There are 2 other peers that have a rating on AVDL. Out of the 2 peers that are also analyzing AVDL, 0 agree with Ami's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Ami

  • Francois Brisebois of "Oppenheimer" Reiterated at Buy and Held Target at $20 on, Monday, April 3rd, 2023
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $14 on, Thursday, March 23rd, 2023

Contributing Sources